Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 132,858 | 66,687 | N/A | N/A | N/A |
| Receivables | 2,427 | 3,157 | N/A | N/A | N/A |
| TOTAL | $139,526 | $70,668 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,615 | 2,491 | N/A | N/A | N/A |
| Intangibles | 3,881 | 4,646 | 0 | 0 | 0 |
| Other Non-Current Assets | 300 | 186 | 0 | 0 | 0 |
| TOTAL | $6,796 | $7,323 | $N/A | $N/A | $N/A |
| Total Assets | $146,322 | $77,991 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,297 | 6,588 | 0 | 0 | 0 |
| TOTAL | $12,709 | $17,096 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,411 | 10,508 | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $12,709 | $17,096 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 22,936 | N/A | N/A |
| Common Shares | 3,747 | 3,020 | N/A | N/A | N/A |
| Retained earnings | 123,562 | 52,586 | N/A | N/A | N/A |
| Other shareholders' equity | 6,305 | 5,289 | 0 | 0 | 0 |
| TOTAL | $133,613 | $60,895 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $146,322 | $77,991 | $0 | $0 | $0 |